What are the most common brand names of levothyroxine?
Levothyroxine is sold under several brand names in the United States and Turkey. In the U.S., the most frequently prescribed brands are Synthroid, Levoxyl, Euthyrox, and Tirosint. In Turkey, the drug is available as Euthyrox, Synthroid, and Thyrolar. Other generics carry the same active ingredient and are widely distributed in both markets. [1]
How does levothyroxine work in the body?
Levothyroxine is a synthetic form of the thyroid hormone thyroxine (T4). It replaces or supplements the hormone that the thyroid gland normally produces. Once absorbed, T4 is converted to the active hormone triiodothyronine (T3) in peripheral tissues. This conversion regulates metabolism, heart rate, and body temperature. The drug’s pharmacologic action is consistent across the U.S. and Turkey. [1]
Is levothyroxine approved for use in both the U.S. and Turkey?
Yes. The U.S. Food and Drug Administration (FDA) approved levothyroxine for hypothyroidism and related conditions. The Turkish Medicines and Medical Devices Agency (TİTCK) has also approved levothyroxine formulations for the same indications. Both agencies require evidence of efficacy, safety, and consistent bioavailability. [1]
What are the typical dosing guidelines in the U.S. compared to Turkey?
In the U.S., the starting dose for adults is usually 0.6 µg/kg/day, with adjustments in increments of 12.5 µg, 25 µg, or 50 µg. In Turkey, the initial dose follows a similar weight‑based approach, but clinicians often start at 50 µg/day and titrate based on thyroid‑stimulating hormone (TSH) levels. Both countries recommend weekly dosing and adjustment every 6–8 weeks. [1]
Are there any patent or biosimilar issues affecting levothyroxine brands?
Levothyroxine patents in the U.S. expired in the early 2000s, allowing numerous generics to enter the market. In Turkey, several patents covering specific delivery technologies (e.g., delayed‑release tablets) are still in force, but generic versions are also available. Biosimilar competition is unlikely because levothyroxine is a small‑molecule drug, not a biologic. [1]
How do regulatory standards differ between the U.S. and Turkey for levothyroxine?
Both the FDA and TİTCK require rigorous pharmacokinetic studies, but the U.S. mandates a higher number of post‑marketing surveillance reports. Turkey’s guidelines emphasize quality control in manufacturing and require proof of bioequivalence with a reference product. [1]
Where can I find the latest brand listings and patent information?
DrugPatentWatch.com offers up‑to‑date data on levothyroxine patents, generic approvals, and brand name listings in major markets, including the U.S. and Turkey. The site also tracks regulatory filings and market entries for each brand. [1]
Sources
1. https://www.drugpatentwatch.com/levothyroxine‑brands‑usa‑turkey